Aberrant DNA Methylation in Non-Neoplastic Gastric Mucosa of H. Pylori Infected Patients and Effect of Eradication
Authors:
- Rosa CotugnoRCRosa Cotugno
- Ada PiepoliAPAda Piepoli
- Antonio MerlaAMAntonio Merla
- Michele QuitadamoMQMichele Quitadamo
- Annamaria GentileAGAnnamaria Gentile
- Alberto PilottoAPAlberto Pilotto
- Vito AnneseVAVito Annese
- Angelo AndriulliAAAngelo Andriulli
- 1 July 2007
- journal article
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 102 (7) , 1361-1371
Abstract
Gene promoter methylation is an epigenetic event leading to gene silencing. This mechanism is particularly relevant in cancer since it can interfere with the activity of specific "suppressor" genes. To evaluate promoter methylation of CDH1, p16, APC, MLH1, and COX2 in patients with H. pylori (Hp) infection before and after eradication. Fifty-seven dyspeptic outpatients who had never performed previous endoscopy or Hp testing and treatment underwent clinical interview, endoscopy with three paired gastric biopsy specimens from the antrum, angulus, and corpus, and (13)C-urea breath test (UBT). Biopsies were scored for the presence of Hp and intestinal metaplasia (IM). DNA methylation of five tumor-related genes (CDH1, p16, MLH1, APC, and COX2) was evaluated by methylation-specific PCR in each biopsy. Infected patients were given a standard eradicating treatment and, after 1 yr, underwent endoscopy with biopsies and UBT. Hp infection was found in 45 patients. IM was detected in 17 out of 45 (38%) infected patients. Mean number of methylated genes was 0, 1.1 +/- 0.9, and 1.6 +/- 0.9 among the 12 Hp-/IM-, the 28 Hp+/IM-, and the 17 Hp+/IM+ patients, respectively (P < 0.0001). Specifically, promoter hypermethylation of CDH1, p16, APC, MLH1, and COX2 was found in 68%, 25%, 7%, 0%, and 14% of Hp+/IM- patients and in 71%, 29%, 35%, 12%, and 12% of Hp+/IM+ patients. No significant difference was found among the three groups of patients as far as age, smoking, alcohol, meat and vegetable consumption, and family history of gastric cancer were considered. Twenty-three out of 45 (51%) infected patients underwent the 1-yr follow-up endoscopy: 17 out of 23 (74%) were successfully eradicated. After Hp eradication, CDH1, p16, and APC methylation significantly decreased while COX2 methylation completely disappeared. Conversely, MLH1 methylation did not change significantly in patients with IM. Hp infection is associated with promoter methylation of genes which are relevant in the initiation and progression of gastric carcinogenesis. While CDH1 methylation seems to be an early event in Hp gastritis, MLH1 methylation occurs late along with IM. Hp eradication is able to significantly reduce gene methylation thus delaying or reversing Hp-induced gastric carcinogenesis.Keywords
This publication has 43 references indexed in Scilit:
- Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancerWorld Journal of Gastroenterology, 2006
- Gene Silencing in Cancer in Association with Promoter HypermethylationNew England Journal of Medicine, 2003
- DNA methylation and histone deacetylation associated with silencing DAP kinase gene expression in colorectal and gastric cancersBritish Journal of Cancer, 2002
- Epstein-Barr Virus-Positive Gastric Carcinoma Demonstrates Frequent Aberrant Methylation of Multiple Genes and Constitutes CpG Island Methylator Phenotype-Positive Gastric CarcinomaThe American Journal of Pathology, 2002
- Methylation ofO6-methylguanine-DNA methyltransferase gene is associated significantly withK-ras mutation, lymph node invasion, tumor staging, and disease free survival in patients with gastric carcinomaCancer, 2001
- Aberrant methylation and histone deacetylation of cyclooxygenase 2 in gastric cancerInternational Journal of Cancer, 2001
- Alterations and hypermethylation of thep14ARF gene in gastric cancerInternational Journal of Cancer, 2000
- Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epitheliaOncogene, 2000
- E-Cadherin Gene Promoter Hypermethylation in Primary Human Gastric CarcinomasJNCI: Journal of the National Cancer Institute, 2000
- Distinct methylation pattern and microsatellite instability in sporadic gastric cancerInternational Journal of Cancer, 1999